1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )Table 2:Metabolite concentrations in cerebral white matter of 7 patients with X-ALD and 14 controls (in vivo)
Center of Lesion (mean) Edge of Lesion (mean) NAWM (mean) Controls (mean) MTR (%) 11.5 ± 3.3a 23.0 ± 1.5a 29.0 ± 2.5 31.8 ± 1.5 ADC (10−3 mm2/s) 2.1 ± 0.4a 1.2 ± 0.5a 0.83 ± 0.05 0.81 ± 0.07 FA 0.20 ± 0.04a 0.30 ± 0.05a 0.43 ± 0.02 0.37 ± 0.04a tCr (mmol/L) 2.7 ± 0.9a 4.3 ± 0.5 4.8 ± 1.0 4.5 ± 0.6 tNAA (mmol/L) 1.9 ± 1.8a 4.9 ± 1.9a 7.2 ± 0.9 7.7 ± 1.0 Cho (mmol/L) 1.4 ± 0.9 1.9 ± 0.3b 1.5 ± 0.4 1.3 ± 0.2 mIns (mmol/L) 5.0 ± 1.5a 4.8 ± 0.6a 4.2 ± 1.1 3.6 ± 0.3 Lac (mmol/L) 1.8 ± 2.0a 2.3 ± 2.5b 0.5 ± 0.6 0.2 ± 0.3
a Significantly different from NAWM (P< .01).
b Significantly different from NAWM and center of lesion (P< .01).